Insider Financial
All posts tagged "FDA"
-
304BiotechMarinus Pharmaceuticals Inc (NASDAQ:MRNS) Might Be At The Start Of A Longer Term Revaluation
Back in January, we published this piece outlining our thoughts on Marinus Pharmaceuticals Inc (NASDAQ:MRNS). At the time, the company had just...
-
1.0KBiotechAcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Continues To Soar
Readers are running out of time to pick up an exposure to AcelRx Pharmaceuticals Inc (NASDAQ:ACRX). We first highlighted this company back...
-
906BiotechForget The Shorts And Buy Novavax Inc (NASDAQ:NVAX)
It has only been a week since we last looked at Novavax Inc (NASDAQ:NVAX) but recent events necessitate a follow-up early this...
-
769BiotechAnavex Life Sciences Corp. (NASDAQ:AVXL) Just Gave Investors A Big Discount
The small cap biotechnology space has a reputation for being incredibly volatile and – by proxy – incredibly risky for the uninitiated...
-
1.0KBiotechTearLab Corp (NASDAQ:TEAR) Is Set To Run Further On Discovery Approval
TearLab Corp (NASDAQ:TEAR) was a real end of the week runner last week. The company closed out the session on July 20...
-
622BiotechNovocure Ltd (NASDAQ:NVCR) Is a Strong And Pertinent Biotech Play
Brain cancer, specifically glioblastoma multiforme (GBM) is very much a hot topic at the moment. With news hitting press that Senator McCain has...
-
749BiotechPernix Therapeutics Holdings Inc (NASDAQ:PTX): Heading In The Right Direction
It’s only been a few days since we suggested Pernix Therapeutics Holdings Inc (NASDAQ:PTX) might be in line for a breakout. The...
-
905BiotechCan CymaBay Therapeutics Inc (NASDAQ:CBAY) Continue On Its Superb Run?
CymaBay Therapeutics Inc (NASDAQ:CBAY) has been one of the small cap biotechnology space’s most consistent performers during 2017 to date. The company...
-
830BiotechNovavax Inc (NASDAQ:NVAX) Is Finally Starting To Pay Off
Back in May this year we urged our readers to look beyond the share price with Novavax Inc (NASDAQ:NVAX) and weigh the...
-
1.0KBiotechCapricor Therapeutics Inc (NASDAQ:CAPR) Just Scored A Huge Potential Payday
Capricor Therapeutics Inc (NASDAQ:CAPR) ran up close to 100% during the session on Tuesday, closing out at $1.36 a share. Many will...